Skip to navigation | Skip to main content | Skip to footer

We welcome your feedback

Please help us improve The University of Manchester website by completing a short questionnaire at the end of your visit.

Yes, I'll give feedback No, thanks

Read our privacy notice

Menu Search the University of Manchester siteSearch
Search type

Alternatively, use our A–Z index

Dr Eleanor Cheadle (PhD, BSc (Hons), FHEA) - personal details

Contact details

Role: Postdoctoral Research Fellow

Tel: +44 (0)161 918 7006


Institute of Cancer Sciences
The University of Manchester
Wilmslow Road
M20 4BX

Fax: + 44 (0) 161 446 3268




I undertook my PhD at the University of Leeds from 1999-2002 studing recombinant mycobacterial cancer vaccines and their interaction with dendritic cells and lymphocytes under the supervision of Dr Andrew Jackson and Professor Peter Selby. I then moved to the University of Manchester in 2002 where I began work as a postdoctoral research associate in the group of Professor Robert Hawkins and Dr David Gilham. My work focused on the generation and testing of chimeric antigen receptor (CAR) T-cells targeting CD19 for use in the treatment of B-cell malignancies. This work led to an ongoing Kay Kendall Leukaemia funded Phase I clinical trial testing CD19 CAR T-cells in B-cell lymphoma. In 2009 I joined the Targeted Therapy group led by Professor Tim Illidge and my research has focused on investigating the mechanisms of action of type I and type II anti-CD20 antibodies and improving their efficacy in B-cell malignancies through the use of immunomodulatory agents to enhance adaptive immune responses.

Memberships of Committees and Professional Bodies

British Society for Immunology

Fellow of the Higher Education Academy


PhD Cancer Immunology (University of Leeds)

B.Sc (Hons) Biochemistry with Molecular and Cellular Biology (University of Birmingham)

Fellow of the Higher Education Academy


I am a postdoctoral Research Fellow within the Targeted Therapy Group.

I supervise a number of projects within the group looking at combining anti-CD20 mAbs with immuno-modulatory agents to enhance antibody effector mechanisms and the generation of anti-tumour immune responses.

Supervise PhD and undergraduate project students.

Member of the Cancer Research UK Manchester Institute Biosafety Committee.

Unit leader for the MRes Oncology Research Project component.

Sit on the Institute of Cancer Sciences International Student Committee


Unit leader for the MRes Oncology Research Project components

MRes Oncology Tutorials

MBChB PEP assessment

Supervision of BSc Pathology and MBChB undergratuate research projects

Supervision of PhD students

Sit on the ICS International Student Committee